High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.

Keywords

Medicine, Melanoma, Internal medicine, Randomized controlled trial, Gastroenterology

References

• The Large Sample Distribution of the Weighted Log Rank Statistic Under General Local AlternativesMarian Ewell, Joseph G. Ibrahim — 1997
• Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.J M Kirkwood, M H Strawderman, Marc S. Ernstoff — 1996
• Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.Antônio C. Buzaid, Merrick I. Ross, Charles M. Balch — 1997
• Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group.Hubert Pehamberger, H. Peter Soyer, Andreas Steiner — 1998
• A Comparison of Prognostic Factors and Surgical Results in 1,786 Patients with Localized (Stage I) Melanoma Treated in Alabama, USA, and New South Wales, AustraliaCharles M. Balch, Seng‐Jaw Soong, G. W. Milton — 1982
• A Multifactorial Analysis of Melanoma: III. Prognostic Factors in Melanoma Patients with Lymph Node Metastases (Stage II)Charles M. Balch, Seng‐Jaw Soong, Tariq M. Murad — 1981
• A Multifactorial Analysis of Melanoma: Prognostic Histopathological Features Comparing Clark's and Breslow's Staging MethodsCharles M. Balch, Tariq M. Murad, Seng‐Jaw Soong — 1978
• Model predicting survival in stage I melanoma based on tumor progression.W. H. Clark, David E. Elder, DuPont Guerry — 1989
• Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study.Bernard F. Cole, Richard D. Gelber, J M Kirkwood — 1996
• Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma.Edward T. Creagan, Robert J. Dalton, David L. Ahmann — 1995
• Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from Eastern Cooperative Oncology Group 1684.Bruce E. Hillner, John M. Kirkwood, Michael B. Atkins — 1997
• Evaluation of efficacy of adjuvant rIFN-alfa-2a in melanoma patients with regional nodal metastases (abstract)N. Cascinelli — 1995

Cited by

• The Sunbelt Melanoma TrialMichael E. Egger, Charles R. Scoggins, Kelly M. McMasters — 2019
• Diagnostik und adjuvante Therapie des malignen MelanomsHjalmar Kurzen, Helmut Näher — 2002
• Biological and clinical developments in melanoma vaccinesLeopoldo Arribas — 2001
• Cytokines: interleukin and interferon therapy in dermatologyШамардин Александр Александрович — 2002
• Immunization of Patients with Malignant Melanoma with Autologous CD34+ Cell-Derived Dendritic Cells Transduced Ex Vivo with a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene: A Phase I TrialYüko Kawaguchi — 2003
• Melanoma in children and adolescents.Alberto S. Pappo — 2003
• New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-α) treatment of human cancerKimberly Miller — 2004
• Pegylated interferons: prospects for the use in the adjuvant and palliative therapy of metastatic melanoma.Silvana Balbi de, Guido Devoto, Gabriel M. Ingo — 2010
• Aktuelle Aspekte der adjuvanten Therapie des malignen MelanomsVictor Lesser, H. Nawab, Malini Bhandaru — 2010
• Relaxed Poisson cure rate modelsPierre L. Siklos — 2016
• Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapyCarlos Alberto Teles — 2017
• Adjuvant therapy for resected stage III melanoma patients: high-dose interferon-alpha versus ipilimumab combined with kinases inhibitors.Ettore Minutilli, Claudio Feliciani — 2012
• Interferón en el tratamiento del melanomaAlvaro Vazquez Delgado — 2006
• Advances in Adjuvant Therapy: Potential for Prognostic and Predictive BiomarkersDiwakar Davar, Ahmad A. Tarhini, Helen Gogas — 2014
• Cutaneous melanoma: Taiwan experience and literature review.John Wen‐Cheng Chang — 2010
• Adjuvante Interferontherapie beim HochrisikomelanomAxel Hauschild, C Kähler — 2007
• Cancer immunotherapy: current status and future directions.Fumito Ito, Alfred E. Chang — 2013
• Pulmonary and cutaneous sarcoidosis associated with interferon therapy for melanoma.F. Pelletier, P. Manzoni, P. Jacoulet — 2007
• Malignes MelanomErwin Schultz, Gerold Schuler — 2005
• Adjuvant therapy of melanoma.Lynn E. S̄pitler — 2002

Related papers

• Pedicled Flaps for Lower Extremity Reconstruction in the Elderly: A Retrospective Study of 16 CasesCharles E. Dumont, Hanna Neumann, Erich J. Lingenfelter — 2004
• Repair of incisional hernias.H S Khaira, P. Lall, Boyd Hunter — 2001
• Requirement and postoperative outcomes of abdominal panniculectomy alone or in combination with other procedures in a bariatric surgery unit.Joaquín Ortega, Vicente Navarro, Norberto Cassinello Fernández — 2010
• Day‐case laparoscopic hernia repairD S Evans, Paula Ghaneh, Iftikhar Khan — 1996
• Postoperative chylothorax.Robert J. Cerfolio, Mark S. Allen, Claude Deschamps — 1996
• Melanoma without Sentinel Lymph Node Involvement: Patients Have Increased Risk of Recurrence Detected by DecisionDx-MelanomaNicolas Aguila, Paul Toomey — 2019
• Reoperation for postoperative recurrence of hyperthyroidism:a report of 34 casesYuan Liu — 2003
• [Surgical treatment of spinal tuberculosis in aged].Hai-bin Xue, Yuanzheng Ma, Xing Chen — 2007
• MacFee Incision: A Safe Approach to the NeckKL White, Dale M. Mosdell, Don M. Morris — 1993